BIRMINGHAM, Ala., and SAN DIEGO, Calif., May 15, 2026
Guideway Care announced the appointment of nationally recognized healthcare and clinical leaders to its new Patient Activation Clinical Advisory Board, strengthening the company’s push to improve healthcare execution beyond the traditional point of care. The advisory board includes experts associated with Mayo Clinic, UAB Health System, Fox Chase Cancer Center, CommonSpirit Health, RAYUS Radiology, and the American Board of Ophthalmology. The company aims to expand its “Enterprise Evidence-Based Patient Activation” strategy, designed to improve referral completion, care transitions, chronic disease management, preventive care adherence, and patient retention using a human-plus-AI operational model.
Guideway Care stated that healthcare systems often struggle not because of a lack of medical evidence, but because patients fail to complete recommended next steps after clinical encounters. The company’s Activation Intelligence platform combines behavioral science, AI-driven workflow orchestration, and patient navigation support to improve follow-through across the healthcare journey. According to the company, failures in referral closure, post-discharge follow-up, and preventive care continue to create significant financial and clinical burdens across hospitals and health systems. The new advisory board will help shape clinical, scientific, and operational frameworks supporting broader adoption of activation-centric healthcare delivery models.
Key Healthcare Leaders Join Advisory Board
The newly formed advisory board includes several prominent healthcare executives and physician leaders. Among them is Edward E. Partridge, former president of the American Cancer Society and longtime leader of UAB’s cancer enterprise. Partridge has been a strong advocate of patient navigation programs designed to reduce disparities in cancer care and improve patient outcomes. His prior work on patient navigation research published in JAMA Oncology demonstrated reductions in hospitalizations, emergency visits, and ICU admissions among Medicare cancer patients.
Additional board members include George Bartley, former Chair of Ophthalmology at Mayo Clinic; Martin Heslin; Yagnesh B. Patel; Anna Liza Rodriguez; and James Backstrom. These leaders bring expertise across oncology, radiology, nursing leadership, quality management, specialty medicine, and enterprise healthcare operations. Guideway Care believes this multidisciplinary perspective will support broader implementation of patient activation science across large health systems and accountable care organizations.
AI, Patient Activation, and Healthcare Execution
Advertisement
Guideway Care emphasized that healthcare’s next challenge is not simply improving diagnostics or treatment decisions, but ensuring patients actually complete recommended actions in real-world settings. The company’s “Activation-Based Care” model applies AI-assisted workflows, longitudinal barrier analysis, and behavioral insights to increase patient compliance with referrals, screenings, chronic care plans, and follow-up visits. Rather than relying on passive digital engagement, Guideway positions its system as an execution-focused infrastructure designed to improve measurable healthcare outcomes.
Company executives highlighted that healthcare organizations are increasingly investing in AI-driven systems, but many still struggle with trust-sensitive patient engagement and long-term adherence. Guideway Care argues that combining human activation specialists with AI agents can improve both patient experience and enterprise performance. CEO Craig Parker stated that referrals still fail to close, preventive care remains incomplete, and many patients leave health systems because the next step in care was not made clear or accessible. The company sees its Activation Intelligence model as a way to bridge the gap between Evidence-Based Medicine and actual patient action.
Source: Guideway Care press release
